Overview of managing medical comorbidities in patients with severe mental illness

Roger S McIntyre1

  • 1Department of Psychiatry and Pharmacology, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.

Insights

Patients with severe mental disorders face higher mortality, primarily from cardiovascular disease (CVD). Addressing obesity and metabolic issues through integrated care and weight management is crucial for this population.

Area of Science:

  • Psychiatry and Cardiology
  • Public Health
  • Metabolic Disorders

Background:

  • Severe mental disorders are linked to increased mortality rates compared to the general population.
  • Cardiovascular disease (CVD) is the leading cause of death for individuals with psychotic illnesses or bipolar disorder.
  • Comorbidities like obesity, metabolic syndrome, and diabetes exacerbate CVD risk in this population due to factors including medication side effects and lifestyle challenges.

Purpose of the Study:

  • To highlight the significant burden of cardiovascular disease (CVD) in patients with severe mental illness.
  • To identify the contributing factors to higher CVD rates in this demographic.
  • To propose strategies for mitigating CVD risk in individuals with mental health conditions.

Main Methods:

  • Review of existing literature on mortality rates in severe mental illness.
  • Analysis of the relationship between psychiatric disorders and cardiovascular risk factors.
  • Examination of treatment modalities for managing comorbid physical health conditions.

Main Results:

  • Cardiovascular disease is the primary cause of premature death in patients with severe mental disorders.
  • Obesity, metabolic syndrome, and diabetes are prevalent and contribute to worse CVD outcomes.
  • Inadequate healthcare access, lifestyle factors, and antipsychotic medication side effects compound these risks.

Conclusions:

  • Integrated care models combining psychiatric and somatic treatments are essential.
  • Weight-neutral or weight-reducing medications may help manage medication-induced weight gain.
  • Behavioral weight management programs offer a viable strategy to reduce CVD burden in the mental health population.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
181
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
813
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
406